Nutritional treatments for hereditary retinal degenerations

Acknowledgments  Dedicated to the memory of an exceptional retinal photographer, Peter Buch, who contributed the fundus photographs seen in this chapter

References

1.Dryja, T.P., McGee, T.L., Reichel, E., et al.: A point mutation of the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. Nature 343, 364–366 (1990)

2.McWilliam, P., Farrar, G.J., Kenna, P., et al.: Autosomal dominant retinitis pigmentosa (ADRP): localization of an ADRP gene to the long arm of chromosome 3. Genomics 5, 619–622 (1989)

3.Gregory-Evans, K., Bhattacharya,.S.S.: Genetic blindness: current concepts in the pathogenesis of human outer retinal dystrophies. Trends Genet. 14, 103–108 (1998)

4.Evans, D.M., Cardon, L.R.: Guidelines for genotyping in genome wide linkage studies: single-nucleotide-polymor- phism maps versus microsatellite maps. Am. J. Hum. Genet. 75, 687–692 (2004)

5.Sullivan, L.S., Daiger, S.P.: Inherited retinal degeneration: exceptional genetic and clinical heterogeneity. Mol. Med. Today 2, 380–386 (1996)

6.Weleber, R.G., Kurz, D.E., Trzupek, K.M.: Treatment of retinal and choroidal degenerations and dystrophies: current status and prospects for gene-based therapy. Ophthalmol. Clin. North Am. 16, 583–593, vii (2003)

7.Margalit, E., Maia, M., Weiland, J.D., et al.: Retinal prosthesis for the blind. Surv. Ophthalmol. 47, 335–356 (2002)

8.Travis, G.H., Sutcliffe, J.G., Bok, D.: The retinal degeneration slow (rds) gene product is a photoreceptor disc membrane­ -associated glycoprotein. Neuron 6, 61–70 (1991)

9.Kajiwara, K., Hahn, L.B., Mukai, S., Travis, G.H., Berson, E.L., Dryja, T.P.: Mutations in the human retinal degeneration slow gene in autosomal dominant retinitis pigmentosa. Nature 354, 480–483 (1991)

10.Weleber, R.G., Carr, R.E., Murphey, W.H., Sheffield, V.C., Stone, E.M.: Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/ RDS gene. Arch. Ophthalmol. 111, 1531–1542 (1993)

11.Donders, F.C.: Torpeur de la retin congenital e hereditaire. Ann. Ocul. 34, 270–273 (1855)

12.Leber,T.: Ueber retinitis pigmentosa und angeborene amaurose. Graefes Arch. Clin. Exp. Ophthalmol. 15, 1–25 (1869)

13.Karpe, G.: The basis of clinical electroretinography. Acta Ophthalmol. 23, 1–114 (1945)

14.Arden, G.B., Barrada, A., Kelsey, J.H.: New clinical test of retinal function based on the standing potential of the eye. Br. J. Ophthalmol. 46, 449–467 (1962)

15.Gouras, P.: Electroretinography: some basic principals. Invest. Ophthalmol. 9:557–569 (1970)

16.Marmor, M.F., Zrenner, E.: Standard for clinical electro-­ oculography. International Society for Clinical Electro­ physiology of Vision. Arch. Ophthalmol. 111, 601–604 (1993)

17.Kajiwara, K., Berson, E.L., Dryja, T.P.: Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/ RDS and ROM1 loci. Science 264, 1604–1608 (1994)

18.Wilson, J.H., Wensel, T.G.: The nature of dominant mutations of rhodopsin and implications for gene therapy. Mol. Neurobiol. 28(2), 149–158 (2003)

19.Sorsby, A.: An enquiry into the genetics and pathology of retinitis pigmentosa and other congenital disorders of the eye. Ann. R. Coll. Surg. Engl. 8, 384–386 (1951)

20.Pacione, L.R., Szego, M.J., Ikeda, S., Nishina, P.M., McInnes, R.R.: Progress toward understanding the genetic and biochemical mechanisms of inherited photoreceptor degenerations. Annu. Rev. Neurosci. 26, 657–700 (2003)

21.Reme, C.E., Grimm, C., Hafezi, F., Marti, A., Wenzel, A.: Apoptotic cell death in retinal degenerations. Prog. Retin. Eye Res. 17, 443–464 (1998)

22.Bunker, C.H., Berson, E.L., Bromley, W.C., Hayes, R.P., Roderick, T.H.: Prevalence of retinitis pigmentosa in Maine. Am. J. Ophthalmol. 97, 357–365 (1984)

23.Heckenlively, J.: The frequency of posterior subcapsular

cataract in the hereditary retinal degenerations. Am.

J. Ophthalmol. 93, 733–738 (1982)

24.Sandberg, M.A., Weigel-DiFranco, C., Rosner, B., Berson, E.L.: The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 37, 1693–1698 (1996)

25.Berson, E.L., Simonoff, E.A.: Dominant retinitis pig­

mentosa with reduced penetrance. Further studies of the electroretinogram­ . Arch. Ophthalmol. 97, 1286–1291 (1979)

26.Kriss, A., Jeffrey, B., Taylor, D.: The electroretinogram in infants and young children. J. Clin. Neurophysiol. 9, 373–393 (1992)

27.Fishman, G.A., Gilbert, L.D., Fiscella, R.G., Kimura, A.E., Jampol, L.M.: Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch. Ophthalmol. 107, 1445–1452 (1989)

28.Hao, W., Wenzel, A., Obin, M.S., et al.: Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat. Genet. 32, 254–260 (2002)

29.Berson, E.L., Rosner, B., Sandberg, M.A., et al.: A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch. Ophthalmol. 111, 761–772 (1993)

30.Marmor, M.F.: A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch. Ophthalmol. 111, 1460–1461 (1993)

31.Norton, E.W.: A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch. Ophthalmol. 111, 1460–1465 (1993)

32.Farrar, G.J., Kenna, P.F., Humphries, P.: On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention. EMBO. J. 21, 857–864 (2002)

33.Weleber, R.G., Gregory-Evans, K.: Retinitis pigmentos and allied disorders. In: Ryan, S.J. (ed.), Retina, pp. 362–460. Elsevier, Mosby (2001)

34.Hope, C.I., Bundey, S., Proops, D., Fielder, A.R.: Usher syndrome in the city of Birmingham–prevalence and clinical classification. Br. J. Ophthalmol. 81, 46–53 (1997)

35.Boughman, J.A., Vernon, M., Shaver, K.A.: Usher syndrome: definition and estimate of prevalence from two high-risk populations. J. Chronic. Dis. 36, 595–603 (1983)

36.Fishman, G.A., Kumar, A., Joseph, M.E., Torok, N., Anderson, R.J.: Usher’s syndrome. Ophthalmic and neurootologic findings suggesting genetic heterogeneity. Arch. Ophthalmol. 101, 1367–1374 (1983)

37.Wolfrum, U.: The cellular function of the usher gene product myosin VIIa is specified by its ligands. Adv. Exp. Med. Biol. 533, 133–142 (2003)

38.Ahmed, Z.M., Riazuddin, S., Riazuddin, S., Wilcox, E.R.: The molecular genetics of Usher syndrome. Clin. Genet. 63, 431–444 (2003)

39.Rider, J.A., Rider, D.L.: Batten disease: past, present, and future. Am. J. Med. Genet. 5(suppl), 21–26 (1988)

40.Birch, D.G.: Retinal degeneration in retinitis pigmentosa and neuronal ceroid lipofuscinosis: an overview. Mol. Genet. Metab. 66, 356–366 (1999)

41.Mantel, I., Brantley, M.A., Bellman, C., et al.: Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sipling pair and low intensity in vivo autofluorescence. Klin Monatsbl Augenheilkd. 221(5), 427–430 (2004)

42.Santavuori, P., Vanhanen, S.L., Sainio, K., et al.: Infantile neuronal ceroid-lipofuscinosis (INCL): diagnostic criteria. J. Inherit. Metab. Dis. 16, 227–229 (1993)

43.Bielschowsky, M.: Uber spat-infantile familiare amau­ rotische Idiote mit Kleinhirnsymmen. Dtsch. Zschr. Nervenheilk. 50, 7–29 (1913)

44.Zemen,W.: Batten disease ocular features, differential diagnosis and diagnosis by enzyme analysis. Birth Defects Orig. Artic. Ser. 12, 441–453 (2005)

45.Katsanis, N., Lupski, J.R., Beales, P.L.: Exploring the molecular basis of Bardet-Biedl syndrome. Hum. Mol. Genet. 10, 2293–2299 (2001)

46.Heon, E., Westall, C., Carmi, R., et al.: Ocular phenotypes of three genetic variants of Bardet-Biedl syndrome. Am. J. Med. Genet. A 132, 283–287 (2005)

47.Farag, T.I., Teebi, A.S.: High incidence of Bardet Biedl syndrome among the Bedouin. Clin. Genet. 36, 463–464 (1989)

48.Poll-The, B.T., Billette de, V., Abitbol, M., Dufier, J.L., Saudubray, J.M.: Metabolic pigmentary retinopathies: diagnosis and therapeutic attempts. Eur. J. Pediatr. 151, 2–11 (1992)

49.Berson, E.L.: Nutrition and retinal degenerations. Int. Ophthalmol. Clin. 40, 93–111 (2000)

50.Reuber, B.E., Germain-Lee, E., Collins, C.S., et al.: Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders. Nat. Genet. 17, 445–448 (1997)

51.Steinberg, S.J., Dodt, G., Raymond, G.V., et al.: Peroxisome biogenesis disorders. Biochimica et Biophysica Acta 1763(12), 1733–1748 (2006)

52.Mihalik, S.J., Morrell, J.C., Kim, D., et al.: Identification of PAHX, a Refsum disease gene. Nat. Genet. 17, 185–189 (1997)

53.Weinstein, R.: Phytanic acid storage disease (Refsum’s disease): clinical characteristics, pathopysiology and the role of therapeutic apheresis in its management. J. Clin. Apher. 14(4), 181–184 (1999)

54.Brodsky, M.C., Cunniff, C.: Ocular anomalies in the Alagille syndrome (arteriohepatic dysplasia). Ophthalmology 100, 1767–1774 (1993)

55.Millay, R.H., Weleber, R.G., Heckenlively, J.R.: Ophthal­ mologic and systemic manifestations of Alstrom’s disease. Am. J. Ophthalmol. 102, 482–490 (1986)

56.Cogan, D.G., Rodrigues, M., Chu, F.C., Schaefer, E.J.: Ocular abnormalities in abetalipoproteinemia. A clinicopathologic correlation. Ophthalmology 91, 991–998 (1984)

57.Pearce, W.G.: Ocular and genetic features of Cockayne’s syndrome. Can. J. Ophthalmol. 7, 435–444 (1972)

58.Flynn, P., Aird, R.B.: A neuroectodermal syndrome of dominant inheritance. J. Neurol. Sci. 2, 161–182 (1965)

59.Donaldson, M.D., Warner, A.A., Trompeter, R.S., Haycock, G.B., Chantler, C.: Familial juvenile nephronophthisis, Jeune’s syndrome, and associated disorders. Arch. Dis. Child. 60, 426–434 (1985)

60.Senior, B., Friedmann, A.I., Braudo, J.L.: Juvenile familial nephropathy with tapetoretinal degeneration. A new oculorenal dystrophy. Am. J. Ophthalmol. 52, 625–633 (1961)

61.Warady, B.A., Cibis, G., Alon, V., Blowey, D., Hellerstein, S.: Senior-Loken syndrome: revisited. Pediatrics 94, 111–112 (1994)

62.den Hollander, A.I., Roepman, R., Koenekoop, R., et al.: Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog. Retin. Eye Res. 27(4), 391–419 (2008)

63.Perrault, I., Rozet, J.M., Calvas, P., et al.: Retinal-specific guanylate cyclase gene mutations in Leber’s congenital amaurosis. Nat. Genet. 14, 461–464 (1996)

64.Hauswirth, W.W., Aleman, T.S., Kaushal, S.: Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum. Gene. Ther. 19(10), 979–990 (2008)

65.Heckenlively, J.: Retinitis Pigmentosa. J.B. Lippincott, Philadelphia (1988)

66.Gu, S.M., Thompson, D.A., Srikumari, C.R., et al.: Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat. Genet. 17, 194–197 (1997)

67.Marlhens, F., Bareil, C., Griffoin, J.M., et al.: Mutations in RPE65 cause Leber’s congenital amaurosis. Nat. Genet. 17, 139–141 (1997)

68.Morimura, H., Fishman, G.A., Grover, S.A., Fulton, A.B., Berson, E.L., Dryja, T.P.: Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis. Proc. Natl. Acad. Sci. USA 95, 3088–3093 (1998)

69.Mohamed, M.D., Topping, N.C., Jafri, H., et al.: Progression of phenotype in Leber’s congenial amaurosis with a mutation at the LCA5 locus. Br. J. Ophthalmol. 87, 473–475 (2003)

70.Cidecivan, A.V., Hauswirth, W.W., Aleman, T.S., et al.: Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. Hum. Gene. Ther. 20(9), 999–1004 (2009)

71.Jan, J.E., Good, W.V., Freeman, R.D., et al.: Eye-poking. Dev. Med. Child. Neurol. 36, 321–325 (1994)

72.Dryja, T.P.: Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson Memorial Lecture. Am. J. Ophthalmol. 130, 547–563 (2000)

73.Nettleship, E. A history of congenital stationary night blindness in nine consecutive generations. Trans. Ophthalmol. Soc. UK 27, 269 (1907)

74.Dryja, T.P., Hahn, L.B., Reboul, T., Arnaud, B.: Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness. Nat. Genet. 13, 358–360 (1996)

75.Strom, T.M., Nyakatura, G., Apfelstedt-Sylla, E., et al.: An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat. Genet. 19, 260–263 (1998)

76.Bech-Hansen, N.T., Naylor, M.J., Maybaum, T.A., et al.: Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. Nat. Genet. 26, 319–323 (2000)

77.Yamamoto, S., Sippel, K.C., Berson, E.L., Dryja, T.P.: Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat. Genet. 15, 175–178 (1997)

78.Cideciyan, A.V., Zhao, X., Nielsen, L., Khani, S.C., Jacobson, S.G., Palczewski, K.: Null mutations in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man. Proc. Natl. Acad. Sci. USA 95, 328–333 (1998)

79.Fuchs, S., Nakazawa, M., Maw, M., Tamai, M., Oguchi, Y., Gal, A.A.: homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat. Genet. 10, 360–362 (1995)

80.Yamamoto, H., Simon, A., Eriksson, U., Harris, E., Berson, E.L., Dryja, T.P.: Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus. Nat. Genet. 22, 188–191 (1999)

81.Gonzalez-Fernandez, F., Kurz, D., Bao, Y., et al.: 11-cis retinol dehydrogenase mutations as a major cause of the congenital night-blindness disorder known as fundus albipunctatus. Mol. Vis. 5, 41 (1999)

82.Auerbach, E., Godel, V., Rowe, H.: An electrophysiologic and psychophysical study of two forms of congenital stationary night blindness. Invest. Ophthalmol. 8, 332–345 (1945)

83.Miyake, Y., Yagasaki, K., Honguchi, M., Kawase, Y., Kanda, T.: Congenital stationary night blindness with negative electroretinogram: a new classification. Arch. Ophthal­ mol. 104, 1013–1020 (1986)

84.Carr, R.E., Ripps, H., Siegel, I.M., Weale, R.A.: Visual function in congenital stationary night blindness. Invest. Ophthalmol. 5, 508–514 (1966)

85.Ben Simon, G.J., Abraham, F.A., Melamed, S., et al.: Pingelapese achromatopsia: correlation between paradoxical pupillary response and clinical features. Br. J. Ophthalmol. 88(2), 223–225 (2004)

86.Kellner, U., Wissinger, B., Kohl, S., et al.: Molecular genetic findings in patients with congenital cone dysfunction. Mutations in the CNGA3, CNGB3, or GNAT2 genes. Ophthalmologe 101(8), 830–835 (2004)

87.Thiadens, A.A., Slingerland, N.W., Roosing, S., et al.: Genetic etiology and clinical consequences of complete and incomplete achromatopsia. Ophthalmology 116(10), 1984–1989 (2009)

88.Defoort-Dhellemmes, S., Lebrun, T., Arndt, C.F.: Congenital Achromatopsia: electroretinogram in early diagnosis. J. Fr. Ophtalmol. 27(2), 143–148 (2004)

89.Varsanyi, B., Somfai, G.M., Lesch, B., et al.: Optical coherence tomography of the macula in congenital achromatopsia. Invest. Ophthalmol. Vis. Sci. 48(5), 2249–2253 (2007)

90.Kohl, S., Baumann, B., Rosenberg, T., et al.: Mutations in the cone photoreceptor G-protein alpha-subunit gene GNAT2 in patients with achromatopsia. Am. J. Hum. Genet. 71(2), 422–425 (2002)

91.Ladekjaer-Mikkelsen, A.S., Rosenberg, T., et al.: A new mechanism in blue cone monochromatism. Hum. Genet. 98(4), 403–408 (1996)

92.Park, W.L., Sunness, J.S.: Red contact lenses for alleviation of photophobia in patients with cone disorders. Am. J. Ophthalmol. 137(4), 774–775 (2004)

93.McCulloch, C.: Choroideremia: a clinical and pathologic review. Trans. Am. Ophthalmol. Soc. 67, 142–196 (1969)

94.Kaiser-Kupfer, M.I., Ludwig, I.H., de Monasterio, F.M., Valle, D., Krieger, I.: Gyrate atrophy of the choroid and retina. Early findings. Ophthalmology 92, 394–401 (1985)

95.Takki, K.K., Milton, R.C.: The natural history of gyrate atrophy of the choroid and retina. Ophthalmology 88, 292–301 (1981)

96.van Bokhoven, H., van den Hurk, J.A., Bogerd, L., et al.: Cloning and characterization of the human choroideremia gene. Hum. Mol. Genet. 3, 1041–1046 (1994)

97.Seabra, M.C., Brown, M.S., Slaughter, C.A., Sudhof, T.C., Goldstein, J.L.: Purification of component A of Rab geranylgeranyl transferase: possible identity with the choroideremia gene product. Cell 70, 1049–1057 (1992)

98.Simell, O., Takki, K.: Raised plasma-ornithine and gyrate atrophy of the choroid and retina. Lancet 1, 1031–1033 (1973)

99.Barrett, D.J., Bateman, J.B., Sparkes, R.S., Mohandas, T., Klisak, I., Inana, G.: Chromosomal localization of human ornithine aminotransferase gene sequences to 10q26 and Xp11.2. Invest. Ophthalmol.Vis. Sci. 28, 1037–1042 (1987)

100. van den Hurk, J.A., Hendriks, W., van De Pol, D.J., et al.: Mouse choroideremia gene mutation causes photoreceptor cell degeneration and is not transmitted through the female germline. Hum. Mol. Genet. 6, 851–858 (1997)

101. Wang, T., Milam, A.H., Steel, G., Valle, D.: A mouse model of gyrate atrophy of the choroid and retina. Early retinal pigment epithelium damage and progressive retinal degeneration. J. Clin. Invest. 97, 2753–2762 (1996)

102. MacDonald, I.M., Mah, D.Y., Ho, Y.K., Lewis, R.A., Seabra, M.C.: A practical diagnostic test for choroideremia. Ophthalmology 105, 1637–1640 (1998)

103. Valle, D., Walser, M., Brusilow, S.W., Kaiser-Kupfer, M.: Gyrate atrophy of the choroid and retina: amino acid metabolism and correction of hyperornithinemia with

an arginine-deficient diet. J. Clin. Invest. 65, 371–378 (1980)

104. Weleber, R.G., Kennaway, N.G.: Clinical trial of vitamin B6 for gyrate atrophy of the choroid and retina. Ophthalmology 88, 316–324 (1981)

105. Valtonen, M., Nanto-Salonen, K., Heinanen, K., Alanen, A., Kalimo, H., Simell, O.: Skeletal muscle of patients with gyrate atrophy of the choroid and retina and hyperornithinaemia in ultralow-field magnetic resonance imaging and computed tomography. J. Inherit. Metab. Dis. 19, 729–734 (1996)

106. Valtonen, M., Näntö-Salonen, K., Jääskeläinen, S., et al.: Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia. J. Inherit. Metab. Dis. 22(8), 855–866 (1999)

107. Lorda-Sanchez, I.J., Ibañez, A.J., Sanz, R.J., et al.: Choroideremia, sensorineural deafness, and primary ovarian failure in a woman with a balanced X-4 translocation. Ophthalmic Genet. 21(3), 185–189 (2000)

108. Menon, R.K., Ball, W.S., Sperling, M.A.: Choroideremia and hypopituitarism: an association. Am. J. Med. Genet. 34(4), 511–513 (1989)

109. Kawata, A., Hayashi, H., Yoshida, H., et al.: Two siblings of distal hereditary motor neuropathy with choroideremia. Rinsho Shinkeigaku. 30(9), 1010–1012 (1990)

110. Bainbridge, J.W., Ali, R.R.: Success in Sight: the Eyes have it! Ocular Gene Therapy Trials for LCA Look Promising. Gene Ther. 15, 1191–1192 (2008)